Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VORICONAZOLE USP, with a corresponding US DMF Number 25343.
Remarkably, this DMF maintains an Active status since its submission on September 23, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 04, 2015, and payment made on July 14, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II